Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Harvey, 1983, Organic and functional disorders in 2000 gastroenterology outpatients, Lancet, 1, 632, 10.1016/S0140-6736(83)91802-0
Camilleri, 2001, A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome, Arch Intern Med, 161, 1733, 10.1001/archinte.161.14.1733
Muller-Lissner, 2001, Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation, Aliment Pharmacol Ther, 15, 1655, 10.1046/j.1365-2036.2001.01094.x
Bulbring, 1959, The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs, J Physiol, 146, 29, 10.1113/jphysiol.1959.sp006176
Cooke, 1997, 5-HT activates neural reflexes regulating secretion in the guinea-pig colon, Neurogastroenterol Motil, 9, 181, 10.1046/j.1365-2982.1997.d01-41.x
Spiller, 2001, Effects of serotonin on intestinal secretion and motility, Curr Opin Gastroenterol, 17, 99, 10.1097/00001574-200103000-00001
Li, 2001, Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors, Am J Physiol, 281, G916
Grider, 1996, 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons, Am J Physiol, 270, G778
Turvill, 1998, Crucial role for 5-HT in cholera toxin but not Escherichia coli heat-labile enterotoxin-intestinal secretion in rats, Gastroenterology, 115, 883, 10.1016/S0016-5085(98)70260-4
Hillsley, 1998, Direct and indirect actions of 5-hydroxytryptamine on the discharge of mesenteric afferent fibres innervating the rat jejunum, J Physiol, 506, 551, 10.1111/j.1469-7793.1998.551bw.x
Degen, 2001, Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects, Aliment Pharmacol Ther, 15, 1745, 10.1046/j.1365-2036.2001.01103.x
Houghton, 2000, Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers, Aliment Pharmacol Ther, 14, 775, 10.1046/j.1365-2036.2000.00762.x
Prather, 2000, Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome, Gastroenterology, 118, 463, 10.1016/S0016-5085(00)70251-4
Cremonini, 2003, Efficacy of alosetron in irritable bowel syndrome, Neurogastroenterol Motil, 15, 79, 10.1046/j.1365-2982.2003.00389.x
Krumholz, 1999, The 5HT4 partial agonist, Tegaserod, improves abdominal bloating and altered stool consistency in irritable bowel syndrome (IBS), Gut, 45, A260
Spiller, 2000, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome, Gut, 47, 804, 10.1136/gut.47.6.804
Dunlop, 2003, Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS, Gastroenterology, 125, 1651, 10.1053/j.gastro.2003.09.028
Gwee, 2003, Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome, Gut, 52, 523, 10.1136/gut.52.4.523
Linden, 2003, Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis, Am J Physiol, 285, G207
Bearcroft, 1998, Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome, Gut, 42, 42, 10.1136/gut.42.1.42
Houghton, 2003, Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome, Gut, 52, 663, 10.1136/gut.52.5.663
Thompson, 1999, Functional bowel disorders and functional abdominal pain, Gut, 45, II43, 10.1136/gut.45.2008.ii43
Dunlop, 2003, Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome, Am J Gastroenterol, 98, 1578, 10.1111/j.1572-0241.2003.07542.x
Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x
Metcalf, 1987, Simplified assessment of segmental colonic transit, Gastroenterology, 92, 40, 10.1016/0016-5085(87)90837-7
Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3
Munoz, 1989, Highly sensitive determination of catecholamine and serotonin concentrations in plasma by liquid chromatography-electrochemistry, J Chromatogr, 493, 157, 10.1016/S0378-4347(00)82718-8
Pussard, 1996, Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine, Clin Chem, 42, 1086, 10.1093/clinchem/42.7.1086
Miwa, 2001, Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits, Digestion, 63, 188, 10.1159/000051888
Wheatcroft, 2002, Increased entero-endocrine cell numbers in the Trichinella spiralis infected mouse model of post-infectious bowel dysfunction, Gastroenterology, 122, A162
Some, 2002, Urinary excretion patterns of 5-hydroxyindole-3-acetic acid and 5-hydroxytryptophol in various animal species, Life Sci, 71, 2341, 10.1016/S0024-3205(02)02043-X
Gozlan, 1990, Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain, Neurobiol Aging, 11, 437, 10.1016/0197-4580(90)90011-N
Brunello, 1988, Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment, Pharmacol Toxicol, 63, 150, 10.1111/j.1600-0773.1988.tb00930.x
Ternaux, 1981, 5-HT metabolism in the intestinal wall of the rabbit, J Physiol, 77, 319
Kojim, 2002, Modification of 5-hydroxytryptophan-evoked 5-hydroxytryptamine formation of guinea pig colonic mucosa by reactive oxygen species, Jpn J Pharmacol, 88, 114, 10.1254/jjp.88.114
Martin, 1995, Effect of streptozotocin-induced diabetes mellitus on serotonin measures of peripheral tissues in rats, Life Sci, 56, 51, 10.1016/0024-3205(94)00407-J
Celada, 1990, Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity, J Neural Transm Suppl, 32, 149
Bellini, 2003, Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron, Am J Gastroenterol, 98, 2705, 10.1111/j.1572-0241.2003.08669.x
Mossner, 2001, Modulation of serotonin transporter function by interleukin-4, Life Sci, 68, 873, 10.1016/S0024-3205(00)00992-9
Chen, 2002, Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation, Gastroenterology, 123, 2005, 10.1053/gast.2002.37055
Gwee, 1999, The role of psychological and biological factors in postinfective gut dysfunction, Gut, 44, 400, 10.1136/gut.44.3.400
Coates, 2004, Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome, Gastroenterology, 126, 1657, 10.1053/j.gastro.2004.03.013
Yeo, 2004, Association between a functional polymorphism in the serotonin transporter gene and diarrhoea-predominant irritable bowel syndrome in women, Gut, 53, 1452, 10.1136/gut.2003.035451
Blakely, 1998, Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins, Biol Psychiatry, 44, 169, 10.1016/S0006-3223(98)00124-3
Benmansour, 2002, Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter, J Neurosci, 22, 6766, 10.1523/JNEUROSCI.22-15-06766.2002
Dunlop, 2004, Age-related decline in rectal mucosal lymphocytes and mast cells, Eur J Gastroenterol Hepatol, 16, 1011, 10.1097/00042737-200410000-00010
Atkinson, 2004, Platelet depleted plasma 5-hydroxytryptamine (PDP 5-HT) concentration, Gastroenterology, 126, A-93